Turning Point Brands (TPB) saw its stock surge 9.92% in pre-market trading on Wednesday, following the release of its impressive first-quarter 2025 financial results. The company, known for its tobacco and alternative products, significantly outperformed market expectations, driving investor enthusiasm.
The quarterly report revealed that Turning Point's sales reached $106.436 million, handily beating the analyst consensus estimate of $95.8 million by 11.16%. This represents a robust 9.66% increase compared to the same period last year. The company's adjusted earnings per share (EPS) came in at $0.91, surpassing the expected $0.78 by 16.67% and showing a 13.75% year-over-year growth.
Adding to the positive sentiment, Turning Point reaffirmed its 2025 Adjusted EBITDA guidance of $108.0 - $113.0 million, demonstrating confidence in its full-year performance. The company also provided an outlook for its full-year nicotine pouch sales, projecting between $80.0 - $95.0 million, indicating strong growth potential in this segment. These factors combined to fuel investor optimism, leading to the significant pre-market stock price increase.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.